We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

2 FTSE 100 stocks I’d buy

Given everything that’s happened in 2021, Jay Yao writes why he’d buy FTSE 100 stocks Diageo and Reckitt Benckiser at their current share prices.

| More on:

You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.

Although 2020 was a tough year, FTSE 100 stocks Diageo (LSE: DGE) and Reckitt Benckiser (LSE: RB) have done well over the past decade. Both stocks have more than doubled and that’s not counting the dividends that each pay. Given their past performance, overall operational strength, and potential, I’d still buy both companies at their current share prices.

Diageo

Diageo has regained some of its momentum. For the half year ended 31 December 2020, the company reported free cash flow of £1.8bn and management raised the interim dividend by 2% to 27.96p per share. Management is also “cautiously optimistic about the near-term continued recovery” of its business and overall confident in the future.

Should you buy Diageo Plc shares today?

Before you decide, please take a moment to review this report first. Despite ongoing uncertainties from US tariffs to global conflicts, Mark Rogers and his team believe many UK shares still trade at substantial discounts, offering savvy investors plenty of potential opportunities to learn about.

That’s why this could be an ideal time to secure this valuable research – Mark’s analysts have scoured the markets to reveal 5 of his favourite long-term ‘Buys’. Please, don’t make any big decisions before seeing them.

In the future, I reckon Diageo could potentially maintain some of that momentum by utilising data and digital insights to increase marketing effectiveness. Given its financial strength, I think the company could also expand through M&A or by potentially creating new brands.

To me, Diageo has an attractive combination of defensive characteristics and growth potential. Given that its products are affordable for many, demand for Diageo doesn’t change all that much during difficult times. Diageo was still profitable during the recession in 2009 for example. With many of Diageo’s customers in developing nations where incomes will likely grow substantially in the future, I reckon the company could potentially grow earnings in the future too.

With that said, the market is expecting Diageo’s fundamentals to recover pretty strongly given its recent rally. If that doesn’t happen or if Diageo’s brands don’t sell as much as the market expects, the stock has potential downside.

Reckitt Benckiser

Reckitt Benckiser is a consumer staple with a portfolio of leading brands in hygiene, health, and nutrition. Given the company’s scale, Reckitt Benckiser can often realise attractive margins even while spending substantial money on advertising. With its portfolio of leading brands, the company also has a pretty wide moat.

As a leading consumer staple, Reckitt Benckiser benefits from long-term trends such as rising incomes and urbanisation, which often helps increase economic growth. Due to Reckitt Benckiser’s position in the market and its operational strength, I reckon the company has the potential to grow around 4%-6% on average annually in the medium term if management continues to perform as they expect. With that type of growth, I think Reckitt Benckiser earnings per share could grow in the future and management could potentially return more capital back to shareholders.

While management kept the full-year dividend per share for fiscal year 2020 the same at 174.6p, I think they could increase the dividend in later years as the company potentially achieves its goal of strengthening the balance sheet.

Although many leading consumer staples have historically been great companies to own, they face potential challenges from online competition. Given their position as platform operators, companies like Amazon could potentially compete more with Reckitt Benckiser in the future with internal brands. Those internal brands could potentially put pressure on Reckitt Benckiser’s margins or take away some of Reckitt Benckiser’s growth potential. Reckitt Benckiser could also have downside if the economy weakens or if management doesn’t deliver the results the market expects.

Jay Yao has no position in any of the shares mentioned. John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. The Motley Fool UK owns shares of and has recommended Amazon. The Motley Fool UK has recommended Diageo and recommends the following options: long January 2022 $1920 calls on Amazon and short January 2022 $1940 calls on Amazon. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Investing Articles

Forget Rolls-Royce shares, this incredible penny stock is forecast to soar 762%!

Faron Pharmaceuticals shares are forecast to gain 762% in the coming 12 months, mimicking the recent performance of Rolls-Royce shares.

Read more »

Close-up of children holding a planet at the beach
Investing Articles

How to turn a £20,000 ISA into a £20-a-day passive income stream

Does earning regular passive income seem out of your grasp? Break it down to a simple, step-by-step plan, and it’s…

Read more »

UK financial background: share prices and stock graph overlaid on an image of the Union Jack
Investing Articles

3 UK shares tipped to soar 100% (or more) in the next 12 months

Mark Hartley assesses the growth potential of three lesser-known UK shares with optimistic broker targets. Could they double in value…

Read more »

Curtains, happy woman and thinking of future in home, planning and reflection of mindset with view. Window, smile and African girl with vision, ideas and dream for morning inspiration in living room.
Investing Articles

Up 36% in 3 months! Is this beaten-down FTSE 100 growth stock finally ready to rocket?

Sensing a bargain, Harvey Jones snapped up this growth stock whose shares have fallen by half. Suddenly things are starting…

Read more »

Image of happy young people man and woman in basic clothing thinking and touching chin while looking aside isolated over yellow background
Investing Articles

Up 147% with a 6%+ yield and dirt-cheap P/E – yet this FTSE 100 dividend stock still flies under the radar

Harvey Jones flags up an impressive UK-listed dividend stock that may have passed some investors by. What's driving its stellar…

Read more »

Mining truck in a coal open pit mine
Investing Articles

Forget SpaceX! 2 top growth stocks to consider buying in August

Hunting for growth stocks to buy? Ben McPoland spotlights a tech share from across the pond and another in the…

Read more »

Investing Articles

£1,500 buys 447 shares in this UK stock that’s trouncing the FTSE 100

The FTSE 100's up nicely in the past year, but my favourite growth stock from the FTSE 250 has blown…

Read more »

Electric cars charging at a charging station
Investing Articles

Is this $7 stock the next Tesla?

After skyrocketing over the past decade-and-a-half, everyone has heard of Tesla stock. But this $7 upstart is still under the…

Read more »